SARS-CoV-2 infection in patients with sickle cell disease.
作者信息
Argüello-Marina María, López-Rubio Montserrat, Morado Marta
机构信息
Hospital U. Príncipe de Asturias, Madrid, Spain.
Hospital U. La Paz, Madrid, Spain.
出版信息
Med Clin (Engl Ed). 2021 Oct 8;157(7):345-346. doi: 10.1016/j.medcle.2021.03.012. Epub 2021 Sep 10.
Abstract
摘要
相似文献
1
SARS-CoV-2 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒2型感染
Med Clin (Engl Ed). 2021 Oct 8;157(7):345-346. doi: 10.1016/j.medcle.2021.03.012. Epub 2021 Sep 10.
2
Successful use of veno-venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS-CoV-2.成功应用静脉-静脉体外膜肺氧合治疗镰状细胞病合并 SARS-CoV-2 患儿的急性胸部综合征。
Pediatr Pulmonol. 2022 Apr;57(4):1096-1099. doi: 10.1002/ppul.25843. Epub 2022 Feb 1.
3
SARS CoV-2 infection in a patient with sickle cell disease - Atypical presentation.一名镰状细胞病患者感染新型冠状病毒2 - 非典型表现
J Family Med Prim Care. 2021 Apr;10(4):1792-1794. doi: 10.4103/jfmpc.jfmpc_2210_20. Epub 2021 Apr 29.
4
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report.镰状细胞特征与 SARS-CoV-2 诱导的横纹肌溶解症：病例报告。
Am J Case Rep. 2022 Feb 23;23:e934220. doi: 10.12659/AJCR.934220.
5
Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study.患有疼痛危象的镰状细胞病患者中SARS-CoV-2感染的发生率：一项为期12个月的前瞻性队列研究。
Int J Lab Hematol. 2022 Apr;44(2):e87-e90. doi: 10.1111/ijlh.13739. Epub 2021 Oct 15.
6
Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection.镰状细胞特征对 SARS-CoV-2 感染发病率和死亡率的影响。
Blood Adv. 2021 Sep 28;5(18):3690-3693. doi: 10.1182/bloodadvances.2021004977.
7
SARS-CoV-2 infection in patients with sickle cell disease.镰状细胞病患者的新型冠状病毒2型感染
Med Clin (Barc). 2021 Oct 8;157(7):345-346. doi: 10.1016/j.medcli.2021.03.033. Epub 2021 May 11.
8
COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series.发展中国家镰状细胞病患者的 COVID-19 感染：病例系列。
Acta Haematol. 2022;145(1):1-4. doi: 10.1159/000519028. Epub 2021 Sep 17.
9
Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.患有严重急性下呼吸道感染且感染或未感染新冠病毒的儿童之间的差异。
J Infect. 2021 Aug;83(2):e1-e3. doi: 10.1016/j.jinf.2021.05.038. Epub 2021 Jun 12.
10
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.新型冠状病毒肺炎感染对24例镰状细胞病患者的影响。美国密歇根州底特律市一家中心的城市经验。
Hemoglobin. 2020 Jul;44(4):284-289. doi: 10.1080/03630269.2020.1797775. Epub 2020 Jul 28.
引用本文的文献
1
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.红细胞疾病患者中的新型冠状病毒肺炎，来自欧洲登记处ERN-EuroBloodNet的结果
Orphanet J Rare Dis. 2025 Apr 16;20(1):183. doi: 10.1186/s13023-025-03683-7.
2
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.镰状细胞病和镰状细胞性状患者感染新型冠状病毒肺炎的临床结局：文献的批判性评价
Blood Rev. 2022 May;53:100911. doi: 10.1016/j.blre.2021.100911. Epub 2021 Nov 20.
本文引用的文献
1
Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience.镰状细胞病患者感染新冠病毒后的低发病率和死亡率：单中心经验
EJHaem. 2020 Aug 30;1(2):608-614. doi: 10.1002/jha2.87. eCollection 2020 Nov.
2
COVID-19 and sickle cell disease in Bahrain.巴林的 COVID-19 和镰状细胞病。
Int J Infect Dis. 2020 Dec;101:14-16. doi: 10.1016/j.ijid.2020.09.1433. Epub 2020 Sep 24.
3
Prognosis of patients with sickle cell disease and COVID-19: a French experience.镰状细胞病患者与新冠病毒病的预后：法国的经验
Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18.
4
COVID-19 infection and sickle cell disease: a UK centre experience.新型冠状病毒肺炎感染与镰状细胞病：英国一家中心的经验
Br J Haematol. 2020 Jul;190(2):e57-e58. doi: 10.1111/bjh.16779. Epub 2020 Jun 17.
Zotero 插件